EXOZYMES INC.
About EXOZYMES INC.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $70.1K
- Net income
- -$9.2M
- Total assets
- $6.0M
- Market cap
- $79.2M
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Operating income
- -$9.7M
- Net income
- -$9.2M
- EPS (basic)
- $-1.09
- EPS (diluted)
- $-1.09
Balance sheet
- Total assets
- $6.0M
- Current assets
- $3.9M
- Total liabilities
- $2.6M
- Current liabilities
- $1.6M
- Shareholders’ equity
- $3.4M
Cash flow
- Operating cash flow
- -$6.5M
- Investing cash flow
- -$150.2K
- Financing cash flow
- -$27.7K
- Net cash flow
- -$6.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $79.2M
- EPS (diluted)
- $-1.09
- Shares outstanding
- 9.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 13, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $9.2M in FY2023.
- Trading 48% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review EXOZYMES INC..
